Mesothelioma in its advanced stages often proves unresponsive to treatment. But researchers now believe they’ve hit on yet another way to attack the cancer late in the game. The new approach involves genetically modifying immune-system cells so that they seek out and destroy cells harboring the protein mesothelin. Cells that harbor the most mesothelin are